Lack of NK cells and related cytokines in pleural effusion

Chinese Medical Journal (Taipei)

Volumn 58, Issue 3, 1996, Pages 156-162

  Chen, Yuh Min ^a,b   Whang Peng, Jacqueline ^a   Yang, Wen Kuang ^a   Hung, Yi Mei ^a   Lin, Wen Chang ^a   Kuo, Benjamin Ing Tiau ^b   Perng, Reury Perng ^b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Interleukin 12; Interleukin 4; Natural killer cell; Pleural effusion

Indexed keywords

CYTOKINE; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; MALE; MIDDLE AGED; NATURAL KILLER CELL; PLEURA EFFUSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CYTOKINES; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PLEURAL EFFUSION;

EID: 28244443845     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sahn SA. The pleura. Am Rev Respir Dis 1988;138:184-234.
2. Light RW. Pleural diseases. DM 1992;38:261-331.
3. Moisan TM, Chandrasekhar AJ, Robinson J, Mekenna J, Marti G. Distribution of lymphocyte subpopulations in patients with exudative pleural effusions. Am Rev Respir Dis 1978;117:507-11.
4. Mabritto Cl, Ghio P, Scagliotti GV, Pozzi E. Lymphocyte subpopulations analysis in pleural fluid and peripheral blood in patients with lymphocytic pleural effusions. Respiration 1991;58:65-71.
5. Weissler JC, Nicod LP, Toews GB. Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis 1987;135:1353-7.
6. Inoue Y, Shijulo N, Uede T. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients. Jpn J Cancer Res 1990;81:1012-20.
7. Antony VB, Sahn SA, Mossman B, Gail DB, Kalica A. Pleural cell biology in health and disease. Am Rev Respir Dis 1992;145:1236-9.
8. Shimokata K, Saka H, Murate T, Hasegawa YS, Hasegawa T. Cytokine content in pleural effusion-comaprison between tuberculous and carcinomatous pleunsy. Chest 1991;99:1103-7.
9. Agrenius V, Ukale V, WidstrOm O, Kallenius G, Svenson SIB. Quinacrineinduced pleural inflammation in malignant pleurisy: relation between drainage time of pleural fluid and local interleukin-1β levels. Respiration 1993;60:366-72.
10. Antony VB, Godbey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD, Trieter RM. Recruitment of inflammatory cells to the pleural space - chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993;12:7216-23.
11. Chehimi J, Trinchieri G. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 1994;14:149-61.
12. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 1994;84:2261-8.
13. Gately MK. Interleukin-12: a recently discovered cytokine with potential for enhancing cell-mediated immune responses to tumors. Cancer Invest 1993;11:500-6.
14. Puri RK, Siegel JP. Interleukin-4 and cancer therapy. Cancer Invest 1993;11:473-86.
15. Takahashi K, Sone S, Kimura S, Ogura T, Monden Y. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion. Chest 1993;103:1732-8.
16. Albera C, Mabritto l, Ghio P, Scagliotti GV, Pozzi E. Lymphocyte subpopulations analysis in pleural fluid and penpheral blood in patients with lymphocytic pleural effusions. Respiration 1991;58:65-71.
17. Lucivero G, Pierucci G, Bonomo L. Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J 1988;1:337-40.
18. Ribera E, Ocana I, MartinezVazquez JM, Rossell M, EspaNol T, Ruibal A. High level of interferon gamma in tuberculous pleural effusion. Chest 1988;93:308-11.
19. Domagala W, Emeson EE, Koss LG. T and B lymphocyte enumeration in the diagnosis of lymphocyte-rich pleural fluids. Acta Cytol 1981;25:108-10.
20. Okubo Y, Nakata M, Kuroiwa Y, Wada S, Kusama S. NK cells in carcinomatous and tuberculous pleurisy - phenotypic and functional analyses of NK cells in peripheral blood and pleural effusions. Chest 1987;92:500-4.
21. Tepper Rl, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989;57:503-12.
22. Brunda MJ, Gately MK. Interleukin-12: potential role in cancer theray. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. Important Advances in Oncology 1995. Philadelphia: J.B. Lippincott, 1995:318.
23. Johnson CS. Interleukin-1: Therapeutic potential for solid tumors. Cancer Invest 1993;11:600-8.
24. Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg 1993;80:289-97.